Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 296 clinical trials
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults

Background Omega-7 fatty acids are found in the oil extracted from certain fish and nuts like macadamia. Palmitoleic acid is one of the most common omega-7 fatty acids. Many studies suggest that this oil is good for heart health. Researchers want to find out more about these potential benefits. Objective …

fish oil
fatty acids
olive oil
National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 10 views
  • 29 Oct, 2020
  • 1 location
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

This study is a prospective, multicenter phase II study with patients receiving haploidentical transplantation for Severe Aplastic Anemia (SAA). The primary objective is to assess overall survival (OS) at 1 year post-hematopoietic stem cell transplantation (HSCT).

ejection fraction
tacrolimus
neutrophil count
renal function
oximetry
Children's National Medical Center
 (5.4 away) Contact site
  • 51 views
  • 27 Aug, 2020
  • +27 other locations
A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke

Stroke is one of the leading causes death and major functional disability worldwide. Treatment options for acute stroke are limited with many patients having residual neurologic impairment. The purpose of this study is to evaluate the safety and efficacy of elezanumab and assess change in neurologic function in participants following …

Georgetown University Hospital /ID# 216481
 (7.8 away) Contact site
  • 12 views
  • 13 Jan, 2021
  • +30 other locations
Radium-223 in Biochemically Recurrent Prostate Cancer

Background Some men who have been treated for localized prostate cancer with surgery or radiation still show signs of the disease in their blood. This is called biochemically recurrent prostate cancer. Radium-223 is a small molecule. It uses radiation to kill cancer cells and improves survival in advanced prostate cancer. …

National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 0 views
  • 23 Dec, 2020
  • 1 location
Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant

Background Most people with hairy cell leukemia have a BRAF gene mutation. They can be treated with BRAF inhibitors, drugs that target this mutation. For people who do not have this mutation, BRAF inhibitors are not a treatment option. We found that in hairy cell leukemia, when BRAF is not …

National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 0 views
  • 13 Jan, 2021
  • 1 location
Encorafenib Plus Binimetinib for People With BRAF V600E Mutated Relapsed/Refractory HCL

Background Hairy cell leukemia (HCL) does not usually respond to chemotherapy. Most people with HCL have a BRAF gene mutation. This can increase the growth of cancer cells. Vemurafenib has been tested to treat these people. However, researchers think a combination of drugs might work better. Objective To test if …

National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 0 views
  • 13 Jan, 2021
  • 1 location
A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma

Background Metastatic urothelial carcinoma is lethal and has no cure. Response rates to current treatments are modest. Researchers want to find new strategies to treat the disease. In this study, they will test a drug called M7824. The drug is a new immunotherapy that blocks the pathways that cancer cells …

entecavir
metastatic urothelial carcinoma
neutrophil count
lamivudine
renal function
National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 0 views
  • 04 Nov, 2020
  • 1 location
Fostamatinib for Hospitalized Adults With COVID-19

Background COVID-19 is a new disease caused by SARS-CoV-2 that was identified in 2019. Some people who get sick with COVID-19 become ill requiring hospitalization. There are some medicines that may help with recovery. Researchers want to see if a drug called fostamatinib may help people who are hospitalized with …

National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 0 views
  • 09 Jan, 2021
  • +1 other locations
Durvalumab in Combination With Chemotherapy in Virus-infected Patients With Non-small Cell Lung Cancer

This is a phase II trial of durvalumab in combination of platinum-based chemotherapy. Patients with stage IV Non-Small-Cell-Lung Cancer (NSCLC) with human immunodeficiency virus (HIV) infection (cohort 1) or hepatitis B virus (HBV), or hepatitis C virus (HCV) infection (cohort 2) will be eligible. Patients will receive standard platinum-based chemotherapy …

Medstar Washington Hospital Center
 (5.4 away) Contact site
  • 0 views
  • 19 Dec, 2020
  • +1 other locations
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the clinical efficacy and safety of combination therapy with guselkumab and golimumab in participants with moderately to severely active ulcerative colitis (UC).

golimumab
Chevy Chase Clinical Research
 (8.1 away) Contact site
  • 65 views
  • 03 Dec, 2020
  • +159 other locations